These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 14008893)

  • 1. [Clinical and experimental studies on properdin].
    YAMANO S
    Hokkaido Igaku Zasshi; 1961 Oct; 36():613-20. PubMed ID: 14008893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Natural resistence-studies on properdin].
    ADAMSON CA; HEIWINKEL H
    Sven Lakartidn; 1960 Apr; 57():1190-6. PubMed ID: 13791833
    [No Abstract]   [Full Text] [Related]  

  • 3. [The clinical significance of properdin in epidemic hepatitis in children].
    SLEPTSOV AP; IAKOVLEVA SD
    Pediatriia; 1962 Feb; 40():50-5. PubMed ID: 13913853
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum properdin levels and cancer cell homografts in man.
    SOUTHAM CM; PILLEMER L
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):596-601. PubMed ID: 13505801
    [No Abstract]   [Full Text] [Related]  

  • 5. [Congenital non-specific defense factors in vivo. III. Behavior of congenital non-specific defense factors in experimental streptococcal infection].
    NAGAI H; USUI T; HAYAKAWA T; USUI N
    Shonika Kiyo; 1961; 7():321-9. PubMed ID: 14477862
    [No Abstract]   [Full Text] [Related]  

  • 6. [New advances in the study of natural immunity: properdin system].
    PIAZZI G
    Clin Pediatr (Bologna); 1957 Apr; 39(4):312-7. PubMed ID: 13473121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Proceedings: Echinacea activates the properdin system].
    Med Monatsschr; 1976 Jan; 30(1):32-3. PubMed ID: 943683
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of cations in conglutination and in formation of properdinzymosan complex from bovine serum.
    LEON MA
    Proc Soc Exp Biol Med; 1957 Oct; 96(1):202-4. PubMed ID: 13485057
    [No Abstract]   [Full Text] [Related]  

  • 9. Dysfunctional properdin in a Dutch family with meningococcal disease.
    Sjöholm AG; Kuijper EJ; Tijssen CC; Jansz A; Bol P; Spanjaard L; Zanen HC
    N Engl J Med; 1988 Jul; 319(1):33-7. PubMed ID: 3380115
    [No Abstract]   [Full Text] [Related]  

  • 10. Opsonic activity in the newborn: role of properdin.
    Stossel TP; Alper CA; Rosen FS
    Pediatrics; 1973 Jul; 52(1):134-7. PubMed ID: 4724429
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional relationship of factor B in the properdin system to C3 proactivator of human serum.
    Goodkofsky I; Lepow IH
    J Immunol; 1971 Oct; 107(4):1200-4. PubMed ID: 5093780
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement activation in semi-solid medium: Insolubilization of properdin and the third component of complement (C3) in agar gels.
    Ziegler JB; Watson L; Goodkofsky I; Alper CA; Lepow IH
    J Immunol; 1976 Jan; 116(1):75-9. PubMed ID: 812917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the natural polymeric forms of human properdin and their functions in complement activation.
    Pangburn MK
    J Immunol; 1989 Jan; 142(1):202-7. PubMed ID: 2909614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and functional analysis of properdin in zebrafish Danio rerio.
    Zhang Y; Chen J; Yao F; Ji D; Li H; Zhang S
    Dev Comp Immunol; 2013 Jun; 40(2):123-31. PubMed ID: 23416932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Cleavage of the third complement component (C3) and release of a spasmogenic, C3-derived peptide (C3a) by epsilon-aminocaproic acid (EACA) in serum: a process involving the complement activating properdin system.
    Vogt W; Schmidt G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R103. PubMed ID: 4276668
    [No Abstract]   [Full Text] [Related]  

  • 16. [Turnover of properidine in rabbits].
    KELLER H; ISLIKER H; AEBI H
    Helv Physiol Pharmacol Acta; 1957; 15(2):C21-2. PubMed ID: 13474585
    [No Abstract]   [Full Text] [Related]  

  • 17. A properdin system intermediate formed by zymosan and serum at 0 degrees C.
    Yukiyama Y; Lew FT; Waks HS; Osler AG
    J Immunol; 1976 Jan; 116(1):188-93. PubMed ID: 812914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properdin--its biologic importance.
    Alper CA
    N Engl J Med; 1973 Jan; 288(2):109. PubMed ID: 4681974
    [No Abstract]   [Full Text] [Related]  

  • 19. The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
    Ruef J; Kuehnl P; Meinertz T; Merten M
    Platelets; 2008 Aug; 19(5):359-64. PubMed ID: 18791942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Properdin, factor H, factor I].
    Ohsawa I; Tomino Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():77-81. PubMed ID: 20942006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.